EMA panel recommends extending indication for Gilead''s HIV drug Biktarvy to include kids
The European drug regulator''s human medicines committee had recommended a new dosage strength for Gilead Sciences'' (GILD) HIV drug Biktarvy and an extension of its indication
EMA panel recommends extending indication for Gilead''s HIV drug Biktarvy to include kids
The European drug regulator''s human medicines committee had recommended a new dosage strength for Gilead Sciences'' (GILD) HIV drug Biktarvy and an extension of its indication